Related Experiment Video
Updated: Aug 5, 2026
Three Different Protocols of Corneal Collagen Crosslinking in Keratoconus: Conventional, Accelerated and Iontophoresis
Published on: November 12, 2015
Topical mitomycin-C for subepithelial fibrosis after refractive corneal surgery
P A Majmudar1, S L Forstot, R F Dennis
1Cornea Service, Department of Ophthalmology, Rush-Presbyterian-St. Luke's Medical Center, Chicago, Illinois 60612, USA.
Objective:
To determine the effectiveness of mitomycin-C (MMC), 0.02%, in preventing recurrence of corneal subepithelial fibrosis after debridement and/or keratectomy in patients who have undergone refractive corneal surgery.
Design:
Noncomparative case series.
Participants:
Eight eyes of five patients with corneal subepithelial fibrosis who had previously undergone radial keratotomy (n = 4) or photorefractive keratectomy (n = 4).
Intervention:
All eyes underwent epithelial debridement followed by a single intraoperative application of MMC (0.02%) for 2 minutes followed by saline irrigation. The eyes were then patched, or a bandage contact lens placed until epithelial healing was complete.
Main Outcome Measures:
Corneal clarity and best-corrected visual acuity (BCVA).
Results:
In all cases, the cornea remained clear with no recurrence throughout the follow-up period (6-25 mos., mean, 13.8 mos). No adverse reactions were reported. BCVA improved in all cases.
Conclusions:
Subepithelial fibrosis can be a visually disabling condition after refractive corneal surgery. Topical application of MMC (0.02%) may be a successful method of preventing recurrence of subepithelial fibrosis after debridement.
